Additional Paid in Capital of ACTAVIA LIFE SCIENCES, INC. from 30 Jun 2013 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.
Summary
ACTAVIA LIFE SCIENCES, INC. quarterly Additional Paid in Capital in USD history and change rate from 30 Jun 2013 to 31 Mar 2024.
  • ACTAVIA LIFE SCIENCES, INC. Additional Paid in Capital for the quarter ending 31 Mar 2024 was $25,953,197, a 0.37% increase year-over-year.
Source SEC data
View on sec.gov
Additional Paid in Capital, Quarterly (USD)
Additional Paid in Capital, YoY Quarterly Change (%)

ACTAVIA LIFE SCIENCES, INC. Quarterly Additional Paid in Capital (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $25,953,197 +$95,172 +0.37% 31 Mar 2024 10-Q 20 May 2024 2024 Q2
Q4 2023 $25,935,882 +$3,554,591 +16% 31 Dec 2023 10-Q 16 Feb 2024 2024 Q1
Q3 2023 $25,935,882 +$3,583,391 +16% 30 Sep 2023 10-Q 20 May 2024 2024 Q2
Q2 2023 $25,858,025 30 Jun 2023 10-Q 14 Aug 2023 2023 Q3
Q1 2023 $25,858,025 31 Mar 2023 10-Q 15 May 2023 2023 Q2
Q4 2022 $22,381,291 31 Dec 2022 10-Q 02 Mar 2023 2023 Q1
Q3 2022 $22,352,491 +$1,640,733 +7.9% 30 Sep 2022 10-K 05 Jan 2024 2023 FY
Q3 2021 $20,711,758 30 Sep 2021 10-K 09 Feb 2023 2022 FY
Q4 2017 $19,272,299 +$5,257,184 +38% 31 Dec 2017 10-Q 08 Feb 2018 2018 Q1
Q3 2017 $18,267,895 +$5,997,064 +49% 30 Sep 2017 10-Q 08 Feb 2018 2018 Q1
Q2 2017 $17,062,827 +$17,015,032 +35600% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q1
Q1 2017 $16,740,989 +$10,994,512 +191% 31 Mar 2017 10-KT 30 Nov 2017 2017 FY
Q4 2016 $14,015,115 +$13,967,320 +29223% 31 Dec 2016 10-Q 14 Mar 2017 2016 Q3
Q3 2016 $12,270,831 +$12,223,036 +25574% 30 Sep 2016 10-Q/A 14 Mar 2017 2016 Q2
Q2 2016 $47,795 $0 0% 30 Jun 2016 10-K 28 Sep 2016 2016 FY
Q1 2016 $5,746,477 +$5,698,682 +11923% 31 Mar 2016 10-KT 30 Nov 2017 2017 FY
Q4 2015 $47,795 $0 0% 31 Dec 2015 10-Q 17 Feb 2016 2016 Q2
Q3 2015 $47,795 $0 0% 30 Sep 2015 10-Q/A 18 Nov 2015 2016 Q1
Q2 2015 $47,795 $0 0% 30 Jun 2015 10-K 28 Sep 2016 2016 FY
Q1 2015 $47,795 $0 0% 31 Mar 2015 10-Q 14 May 2015 2015 Q3
Q4 2014 $47,795 $0 0% 31 Dec 2014 10-Q 17 Feb 2015 2015 Q2
Q3 2014 $47,795 30 Sep 2014 10-Q 13 Nov 2014 2015 Q1
Q2 2014 $47,795 $0 0% 30 Jun 2014 10-K 30 Sep 2015 2015 FY
Q1 2014 $47,795 31 Mar 2014 10-Q/A 23 May 2014 2014 Q3
Q4 2013 $47,795 31 Dec 2013 10-Q 14 Feb 2014 2014 Q2
Q2 2013 $47,795 30 Jun 2013 10-K 03 Oct 2014 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.